How to Leverage AI Throughout the Pharma Treatment Pipeline


Image Recognition

ARTICLE SOURCE

AI in drug discoveryLong before manufacturers can bring a drug to market, researchers are working to identify the right molecules. The use of AI in drug development is still in the relatively early stages, and no drugs discovered by AI are currently on the market. AI in evaluating treatment outcomesOnce a clinical trial has demonstrated effectiveness, it’s critical to understand the value of a new intervention within the healthcare marketplace. Epidemiologists, researchers, health economists, and others who play a role in the drug development pipeline can all find value from incorporating AI into their work. AI holds limitless potential within healthcare and pharma for improving lives – and it’s our responsibility to leverage it to its greatest capacity.